Meixian Ruan , Qianlong Ai , Guochao Cao , Fengxiao Ren , Zhouyao Zhang , Dekai Wang , Qiaojun Jia
{"title":"基于UPLC-MS、网络药理学和实验验证的何首乌饮片干预2型糖尿病的有效成分及分子机制研究","authors":"Meixian Ruan , Qianlong Ai , Guochao Cao , Fengxiao Ren , Zhouyao Zhang , Dekai Wang , Qiaojun Jia","doi":"10.1016/j.jff.2025.106762","DOIUrl":null,"url":null,"abstract":"<div><div><em>Polygonatum sibiricum</em> beverage (PSB), a functional beverage with hypoglycaemic effects, is based on a formula from the medical book <em>Miao Yong Huangjing Zhi Bai Bing</em>. However, its active ingredients and molecular mechanisms remain unclear. This study aimed to elucidate the mechanisms by which PSB exerted its therapeutic effects on type 2 diabetes mellitus (T2DM) using Ultra Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS), network pharmacology, and experimental validation. UPLC-MS identified 77 compounds in PSB, and network pharmacology predicted 318 potential T2DM-related targets. Key active ingredients, including Withanolide A, Aurantiamide acetate, and N-trans-Feruloyloctopamine, were identified. PSB treatment reduced fasting blood glucose, improved serum lipid profiles (TC, TG, HDL-C, LDL-C), and alleviated liver and pancreatic damage in T2DM mice. RT-qPCR analysis showed that PSB upregulated <em>JUN</em>, <em>JAK2</em>, <em>MAPK3</em>, and <em>GSK-3β</em>, and downregulated <em>PI3K, AKT1</em>. PSB regulated AGE-RAGE and PI3K-AKT pathways. These results suggested that PSB exerted therapeutic effects on T2DM through multi-component, multi-target and multi-pathway mechanisms.</div></div>","PeriodicalId":360,"journal":{"name":"Journal of Functional Foods","volume":"127 ","pages":"Article 106762"},"PeriodicalIF":4.0000,"publicationDate":"2025-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Study on the active ingredients and molecular mechanisms of Polygonatum sibiricum beverage in the intervention of type 2 diabetes mellitus based on UPLC-MS, network pharmacology and experimental validation\",\"authors\":\"Meixian Ruan , Qianlong Ai , Guochao Cao , Fengxiao Ren , Zhouyao Zhang , Dekai Wang , Qiaojun Jia\",\"doi\":\"10.1016/j.jff.2025.106762\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><em>Polygonatum sibiricum</em> beverage (PSB), a functional beverage with hypoglycaemic effects, is based on a formula from the medical book <em>Miao Yong Huangjing Zhi Bai Bing</em>. However, its active ingredients and molecular mechanisms remain unclear. This study aimed to elucidate the mechanisms by which PSB exerted its therapeutic effects on type 2 diabetes mellitus (T2DM) using Ultra Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS), network pharmacology, and experimental validation. UPLC-MS identified 77 compounds in PSB, and network pharmacology predicted 318 potential T2DM-related targets. Key active ingredients, including Withanolide A, Aurantiamide acetate, and N-trans-Feruloyloctopamine, were identified. PSB treatment reduced fasting blood glucose, improved serum lipid profiles (TC, TG, HDL-C, LDL-C), and alleviated liver and pancreatic damage in T2DM mice. RT-qPCR analysis showed that PSB upregulated <em>JUN</em>, <em>JAK2</em>, <em>MAPK3</em>, and <em>GSK-3β</em>, and downregulated <em>PI3K, AKT1</em>. PSB regulated AGE-RAGE and PI3K-AKT pathways. These results suggested that PSB exerted therapeutic effects on T2DM through multi-component, multi-target and multi-pathway mechanisms.</div></div>\",\"PeriodicalId\":360,\"journal\":{\"name\":\"Journal of Functional Foods\",\"volume\":\"127 \",\"pages\":\"Article 106762\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2025-03-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Functional Foods\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1756464625001045\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"FOOD SCIENCE & TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Functional Foods","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1756464625001045","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
Study on the active ingredients and molecular mechanisms of Polygonatum sibiricum beverage in the intervention of type 2 diabetes mellitus based on UPLC-MS, network pharmacology and experimental validation
Polygonatum sibiricum beverage (PSB), a functional beverage with hypoglycaemic effects, is based on a formula from the medical book Miao Yong Huangjing Zhi Bai Bing. However, its active ingredients and molecular mechanisms remain unclear. This study aimed to elucidate the mechanisms by which PSB exerted its therapeutic effects on type 2 diabetes mellitus (T2DM) using Ultra Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS), network pharmacology, and experimental validation. UPLC-MS identified 77 compounds in PSB, and network pharmacology predicted 318 potential T2DM-related targets. Key active ingredients, including Withanolide A, Aurantiamide acetate, and N-trans-Feruloyloctopamine, were identified. PSB treatment reduced fasting blood glucose, improved serum lipid profiles (TC, TG, HDL-C, LDL-C), and alleviated liver and pancreatic damage in T2DM mice. RT-qPCR analysis showed that PSB upregulated JUN, JAK2, MAPK3, and GSK-3β, and downregulated PI3K, AKT1. PSB regulated AGE-RAGE and PI3K-AKT pathways. These results suggested that PSB exerted therapeutic effects on T2DM through multi-component, multi-target and multi-pathway mechanisms.
期刊介绍:
Journal of Functional Foods continues with the same aims and scope, editorial team, submission system and rigorous peer review. We give authors the possibility to publish their top-quality papers in a well-established leading journal in the food and nutrition fields. The Journal will keep its rigorous criteria to screen high impact research addressing relevant scientific topics and performed by sound methodologies.
The Journal of Functional Foods aims to bring together the results of fundamental and applied research into healthy foods and biologically active food ingredients.
The Journal is centered in the specific area at the boundaries among food technology, nutrition and health welcoming papers having a good interdisciplinary approach. The Journal will cover the fields of plant bioactives; dietary fibre, probiotics; functional lipids; bioactive peptides; vitamins, minerals and botanicals and other dietary supplements. Nutritional and technological aspects related to the development of functional foods and beverages are of core interest to the journal. Experimental works dealing with food digestion, bioavailability of food bioactives and on the mechanisms by which foods and their components are able to modulate physiological parameters connected with disease prevention are of particular interest as well as those dealing with personalized nutrition and nutritional needs in pathological subjects.